Covered recipient · General Payments record
JILL L RAYMER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,546.31
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $592.98 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $188.79 | 12 |
| Gilead Sciences, Inc. | $125.00 | 1 |
| Amgen Inc. | $80.09 | 4 |
| GlaxoSmithKline, LLC. | $43.23 | 2 |
| Novo Nordisk AS | $42.34 | 3 |
| Indivior Inc. | $24.61 | 1 |
| Axsome Therapeutics, Inc. | $23.66 | 1 |
| ITI, Inc. | $20.49 | 1 |
| DEXCOM, INC. | $15.43 | 1 |
| Acerta Pharma LLC | $14.91 | 1 |
| SHIELD THERAPEUTICS INC | $14.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.52 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065380 | CMS |
| ABBVIE INC. | $15.25 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065382 | CMS |
| ABBVIE INC. | $118.11 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065384 | CMS |
| ABBVIE INC. | $4.35 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065386 | CMS |
| ABBVIE INC. | $6.37 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065388 | CMS |
| ABBVIE INC. | $3.25 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065390 | CMS |
| ABBVIE INC. | $1.39 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065392 | CMS |
| ABBVIE INC. | $3.76 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065394 | CMS |
| ABBVIE INC. | $2.96 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065396 | CMS |
| ABBVIE INC. | $9.34 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065398 | CMS |
| ABBVIE INC. | $9.69 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065400 | CMS |
| ABBVIE INC. | $7.80 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108065402 | CMS |
| Amgen Inc. | $18.16 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117663305 | CMS |
| Amgen Inc. | $19.74 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117361610 | CMS |
| Amgen Inc. | $15.52 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117663307 | CMS |
| Amgen Inc. | $26.67 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117663309 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.91 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105510190 | CMS |
| Axsome Therapeutics, Inc. | $23.66 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148370485 | CMS |
| Dexcom, Inc. | $15.43 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153367071 | CMS |
| Gilead Sciences, Inc. | $125.00 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133673354 | CMS |
| GlaxoSmithKline, LLC. | $21.90 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116720066 | CMS |
| GlaxoSmithKline, LLC. | $21.33 | 11/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116296579 | CMS |
| Indivior Inc. | $24.61 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144568514 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.49 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143587582 | CMS |
| Novo Nordisk Inc | $14.65 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100524645 | CMS |
| Novo Nordisk Inc | $13.91 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100584086 | CMS |
| Novo Nordisk Inc | $13.78 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100428881 | CMS |
| SHIELD THERAPEUTICS INC | $14.43 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150142886 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.